FDA/NIH Diabetes Public Meeting
This article was originally published in The Pink Sheet Daily
FDA and the National Institutes of Health will hold a joint public meeting May 13 and 14 to discuss the treatment of type 1 and type 2 diabetes mellitus
You may also be interested in...
FDA's Obesity Working Group suggests the agency hold an advisory committee meeting to discuss existing drug therapies for obesity
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.